These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 34925002)

  • 1. Immune Effect of Active Components of Traditional Chinese Medicine on Triple-Negative Breast Cancer.
    Zhao W; Liu J; Li Y; Chen Z; Qi D; Zhang Z
    Front Pharmacol; 2021; 12():731741. PubMed ID: 34925002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The signaling pathways and targets of traditional Chinese medicine and natural medicine in triple-negative breast cancer.
    Yang Z; Zhang Q; Yu L; Zhu J; Cao Y; Gao X
    J Ethnopharmacol; 2021 Jan; 264():113249. PubMed ID: 32810619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Research progress on mechanism of active ingredients in traditional Chinese medicine for gastric cancer].
    Tian YM; Zhou X; Zhao C; Chen HG; Gong XJ
    Zhongguo Zhong Yao Za Zhi; 2020 Aug; 45(15):3584-3593. PubMed ID: 32893547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Research progress on anti-hepatocellular carcinoma mechanism of active ingredients of traditional Chinese medicine].
    Zhang Y; Chen HG; Zhao C; Gong XJ; Zhou X
    Zhongguo Zhong Yao Za Zhi; 2020 Jul; 45(14):3395-3406. PubMed ID: 32726055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Research progress in mechanism of traditional Chinese medicine active ingredients against cervical cancer].
    Su M; Gong XJ; Zhou X
    Zhongguo Zhong Yao Za Zhi; 2019 Feb; 44(4):675-684. PubMed ID: 30989879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SANT, a novel Chinese herbal monomer combination, decreasing tumor growth and angiogenesis via modulating autophagy in heparanase overexpressed triple-negative breast cancer.
    Li QW; Zhang GL; Hao CX; Ma YF; Sun X; Zhang Y; Cao KX; Li BX; Yang GW; Wang XM
    J Ethnopharmacol; 2021 Feb; 266():113430. PubMed ID: 33011366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systems pharmacology in combination with proteomics reveals underlying mechanisms of Xihuang pill against triple-negative breast cancer.
    Xu X; Zhang J; Zhang Z; Wang M; Liu Y; Li X
    Bioengineered; 2020 Dec; 11(1):1170-1188. PubMed ID: 33092442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research Advances in the Intervention of Inflammation and Cancer by Active Ingredients of Traditional Chinese Medicine.
    Huang Y; Cai T; Xia X; Cai Y; Wu XY
    J Pharm Pharm Sci; 2016; 19(1):114-26. PubMed ID: 27096696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the androgen receptor in triple-negative breast cancer.
    Gucalp A; Traina TA
    Curr Probl Cancer; 2016; 40(2-4):141-150. PubMed ID: 27816190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Luteolin suppresses androgen receptor-positive triple-negative breast cancer cell proliferation and metastasis by epigenetic regulation of MMP9 expression via the AKT/mTOR signaling pathway.
    Wu HT; Lin J; Liu YE; Chen HF; Hsu KW; Lin SH; Peng KY; Lin KJ; Hsieh CC; Chen DR
    Phytomedicine; 2021 Jan; 81():153437. PubMed ID: 33352494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virtual screening of the multi-gene regulatory molecular mechanism of Si-Wu-tang against non-triple-negative breast cancer based on network pharmacology combined with experimental validation.
    Zhang Z; Liu J; Liu Y; Shi D; He Y; Zhao P
    J Ethnopharmacol; 2021 Apr; 269():113696. PubMed ID: 33358854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple-negative breast cancer: current state of the art.
    Rastelli F; Biancanelli S; Falzetta A; Martignetti A; Casi C; Bascioni R; Giustini L; Crispino S
    Tumori; 2010; 96(6):875-88. PubMed ID: 21388048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth Inhibitory Efficacy of Chinese Herbs in a Cellular Model for Triple-Negative Breast Cancer.
    Telang NT; Nair HB; Wong GYC
    Pharmaceuticals (Basel); 2021 Dec; 14(12):. PubMed ID: 34959717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple-negative breast cancer: an unmet medical need.
    Hudis CA; Gianni L
    Oncologist; 2011; 16 Suppl 1():1-11. PubMed ID: 21278435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of GPR30 reduces growth of triple-negative breast cancer cells: possible application in targeted therapy.
    Girgert R; Emons G; Gründker C
    Breast Cancer Res Treat; 2012 Jul; 134(1):199-205. PubMed ID: 22290080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saikosaponin D from Radix Bupleuri suppresses triple-negative breast cancer cell growth by targeting β-catenin signaling.
    Wang J; Qi H; Zhang X; Si W; Xu F; Hou T; Zhou H; Wang A; Li G; Liu Y; Fang Y; Piao HL; Liang X
    Biomed Pharmacother; 2018 Dec; 108():724-733. PubMed ID: 30248540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of an immune-suppressed subtype of feline triple-negative basal-like invasive mammary carcinomas, spontaneous models of breast cancer.
    Dagher E; Simbault L; Abadie J; Loussouarn D; Campone M; Nguyen F
    Tumour Biol; 2020 Jan; 42(1):1010428319901052. PubMed ID: 31959092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Research progress on anti-alcoholic gastric injury active components and mechanisms of Chinese herbal medicine].
    Xue-Xue W; Ai-Wu Y; Zhu-Ping T; Ying LI; Can-Wei LI; Meng-Ran F; Wei-Hong L; Peng-Fei G
    Zhongguo Zhong Yao Za Zhi; 2020 Oct; 45(20):4836-4845. PubMed ID: 33350254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA Mutational Status is a Promising Predictive Biomarker for Platinum- based Chemotherapy in Triple-Negative Breast Cancer.
    Tazzite A; Jouhadi H; Benider A; Nadifi S
    Curr Drug Targets; 2020; 21(10):962-973. PubMed ID: 32013831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saikosaponin A Inhibits Triple-Negative Breast Cancer Growth and Metastasis Through Downregulation of CXCR4.
    Wang Y; Zhao L; Han X; Wang Y; Mi J; Wang C; Sun D; Fu Y; Zhao X; Guo H; Wang Q
    Front Oncol; 2019; 9():1487. PubMed ID: 32047724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.